2Gridelli C.Chemotherapy of advanced nonsmall-cell lung cancer in the elderly:an update[J].Grit Rev Oncol Hemato,2000,35(3):219-225 被引量：1
3Desoize B,Madoulet C.Particular aspects of platinum compounds used at present in cancer treatment[J].Crit Rer Oncol Hematol,2002,42(3):317-325 被引量：1
4Ota K.Nedaplatin[J].Gan To Kagaku Ryoho,1996,23(23):379-389 被引量：1
5Ogawa M,Ariyoshi Y.New anticancer drugs under clinical trials in Janpan[J].Hematol Oncol Clin North Am,1994,8(2):277 -287 被引量：1
6Heike Y,Takahashi M,Ohira T,et al.In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice[J].Cancer Chemother Phamacol,1995,35(3):200-204 被引量：1
7Yoshioka T,Gamoh M,Shineha R,et al.A new combination chemotherapy with cis-diammine-glycolatoplatinum(Nedaplatin) and 5-fluorouracil for advanced esophageal cancer[J].Inten Med,1999,38(11):844-848 被引量：1
8Hirata S,Yatsuyanagi E,Yamazaki H,et al.Neoadjuvant chemotherapy for esophageal cancer by administration of nedaplatin alone[J].Gan To Kagaku Ryoho,2000,27(2):221-226 被引量：1
9Hartmann JT,Lipp HP.Toxicity of platinum compounds[J].Expert Opin Pharmacother,2003,4 (6):889-901 被引量：1
1Desoize B, Madoulet C. Particular aspects of platinum compounds used at present in cancer treatment[J]. Crit Rev Oncol Hematol,2002,42(3) :317-325. 被引量：1
2Ogawa M,Ariyoshi Y. New anticancer drugs under clinical trials in Japan[J]. Hematol Oncol Clin North Am, 1994,8(2):277-287. 被引量：1
3Heike Y,Takahashi M,Ohira T, et al. In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice[J].Cancer Chemother Pharmacol, 1995,35(3) :200-204. 被引量：1
4Ota K. Nedaplatin[J]. Gan To Kagaku Ryoho, 1996,23(3):379-387. 被引量：1
5Alberts DS, Fanta PT,Running KL,et al. In vitro phase Ⅱ comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254S), with that of cisplatin and carboplatin against fresh, human ovarian cancers [ J ]. Cancer Chemother Pharmacol, 1997, 39 (6):493-497. 被引量：1
